Drugs / ANP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02665377 Comparator | Sep 2016 → Jan 2022 | acute kidney injury | Sahlgrenska University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ANP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02665377 ↗ |
| Modality | Peptide | “Human Atrial Natriuretic Peptide” NCT02665377 ↗ |